The support of a knowledgeable provider ensures a smoother transition, optimized dosing, and better outcomes
May 2026: A May 1, 2026 update reported that the federal GLP-1 multidistrict litigation now includes 3,636 pending cases, with Mounjaro claims still making up a large share of the docket
Lyophilized powder in sealed glass vial
Consistency is Key: Regular use of semaglutide GLP-1, along with following a balanced diet and exercise routine, can help maintain long-term appetite control
The central issue is whether the labels and warnings gave doctors and patients enough information about serious risks like gastroparesis, bowel obstruction, ileus, and related complications